Abeona Therapeutics
ABEO
ABEO
92 hedge funds and large institutions have $585M invested in Abeona Therapeutics in 2018 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 37 increasing their positions, 22 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
92
Holders Change
+4
Holders Change %
+4.55%
% of All Funds
2.11%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
16
Increased
37
Reduced
22
Closed
12
Calls
$9.11M
Puts
$4.3M
Net Calls
+$4.81M
Net Calls Change
+$1.78M
Top Buyers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$38.6M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$36.7M |
| 3 |
State Street
Boston,
Massachusetts
|
+$10.4M |
| 4 |
PC
PointState Capital
New York
|
+$9.21M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$6.37M |
Top Sellers
| 1 |
Citadel Advisors
Miami,
Florida
|
-$25.6M |
| 2 |
PA
Perceptive Advisors
New York
|
-$15M |
| 3 |
Viking Global Investors
Stamford,
Connecticut
|
-$10.8M |
| 4 |
HCM
Highbridge Capital Management
New York
|
-$6.1M |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$2.41M |
